| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibacterial drug discovery—Then, now and the genomics future
|
Monaghan, Richard L.
|
|
2006
|
71 |
7 |
p. 901-909
9 p.
|
artikel
|
| 2 |
Commensals upon us
|
Alekshun, M.N.
|
|
2006
|
71 |
7 |
p. 893-900
8 p.
|
artikel
|
| 3 |
Crystallizing new approaches for antimicrobial drug discovery
|
Schmid, Molly B.
|
|
2006
|
71 |
7 |
p. 1048-1056
9 p.
|
artikel
|
| 4 |
Dihydrofolate reductase inhibitors as antibacterial agents
|
Hawser, Stephen
|
|
2006
|
71 |
7 |
p. 941-948
8 p.
|
artikel
|
| 5 |
Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?
|
Silver, Lynn L.
|
|
2006
|
71 |
7 |
p. 996-1005
10 p.
|
artikel
|
| 6 |
Editorial
|
Enna, S.J.
|
|
2006
|
71 |
7 |
p. 891-
1 p.
|
artikel
|
| 7 |
Editorial Advisory Board
|
|
|
2006
|
71 |
7 |
p. iii-
1 p.
|
artikel
|
| 8 |
Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view
|
Lynch, A. Simon
|
|
2006
|
71 |
7 |
p. 949-956
8 p.
|
artikel
|
| 9 |
Empirical antibacterial drug discovery—Foundation in natural products
|
Singh, Sheo B.
|
|
2006
|
71 |
7 |
p. 1006-1015
10 p.
|
artikel
|
| 10 |
Glycopeptides: Update on an old successful antibiotic class
|
Pace, John L.
|
|
2006
|
71 |
7 |
p. 968-980
13 p.
|
artikel
|
| 11 |
Natural products — The future scaffolds for novel antibiotics?
|
Butler, Mark S.
|
|
2006
|
71 |
7 |
p. 919-929
11 p.
|
artikel
|
| 12 |
Practical applications and feasibility of efflux pump inhibitors in the clinic—A vision for applied use
|
Lomovskaya, Olga
|
|
2006
|
71 |
7 |
p. 910-918
9 p.
|
artikel
|
| 13 |
Redefining penems
|
Dalhoff, Axel
|
|
2006
|
71 |
7 |
p. 1085-1095
11 p.
|
artikel
|
| 14 |
Structure-based drug design meets the ribosome
|
Franceschi, François
|
|
2006
|
71 |
7 |
p. 1016-1025
10 p.
|
artikel
|
| 15 |
Surveillance uncovers the smoking gun for resistance emergence
|
Verhoef, Jan
|
|
2006
|
71 |
7 |
p. 1036-1041
6 p.
|
artikel
|
| 16 |
Targeting the forgotten transglycosylases
|
Halliday, Judy
|
|
2006
|
71 |
7 |
p. 957-967
11 p.
|
artikel
|
| 17 |
The evolution of peptide deformylase as a target: Contribution of biochemistry, genetics and genomics
|
Yuan, Zhengyu
|
|
2006
|
71 |
7 |
p. 1042-1047
6 p.
|
artikel
|
| 18 |
The forgotten Gram-negative bacilli: What genetic determinants are telling us about the spread of antibiotic resistance
|
Gootz, Thomas D.
|
|
2006
|
71 |
7 |
p. 1073-1084
12 p.
|
artikel
|
| 19 |
The historical delivery of antibiotics from microbial natural products—Can history repeat?
|
Peláez, Fernando
|
|
2006
|
71 |
7 |
p. 981-990
10 p.
|
artikel
|
| 20 |
The role of pharmacodynamic research in the assessment and development of new antibacterial drugs
|
Lister, Philip D.
|
|
2006
|
71 |
7 |
p. 1057-1065
9 p.
|
artikel
|
| 21 |
Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations
|
Buynak, John D.
|
|
2006
|
71 |
7 |
p. 930-940
11 p.
|
artikel
|
| 22 |
Unmet medical needs in antibacterial therapy
|
Rice, Louis B.
|
|
2006
|
71 |
7 |
p. 991-995
5 p.
|
artikel
|
| 23 |
Use of constraint-based modeling for the prediction and validation of antimicrobial targets
|
Trawick, John D.
|
|
2006
|
71 |
7 |
p. 1026-1035
10 p.
|
artikel
|
| 24 |
Use of genomics to select antibacterial targets
|
Pucci, Michael J.
|
|
2006
|
71 |
7 |
p. 1066-1072
7 p.
|
artikel
|
| 25 |
When will the genomics investment pay off for antibacterial discovery?
|
Mills, Scott D.
|
|
2006
|
71 |
7 |
p. 1096-1102
7 p.
|
artikel
|
Tijdschrift beschrijving